Table 1 Association between the expression levels of miR-1976 and the clinicopathological features of patients with lung adenocarcinoma.
From: MiR-1976/NCAPH/P65 axis inhibits the malignant phenotypes of lung adenocarcinoma
Variables | Numbers of patients | χ2 | P value | |
|---|---|---|---|---|
Low expression (229) | High expression (234) | |||
Age(years) | ||||
≤ 65 | 115 | 107 | 0.936 | 0.333 |
> 65 | 114 | 127 | ||
Gender | ||||
Female | 109 | 140 | 6.965 | 0.008 |
Male | 120 | 94 | ||
T stage | ||||
1 | 61 | 94 | 3.105 | 0.002 |
2 | 134 | 116 | ||
3 | 24 | 18 | ||
4 | 10 | 6 | ||
N stage | ||||
0 | 140 | 167 | 2.216 | 0.027 |
1 | 51 | 36 | ||
2 | 36 | 31 | ||
3 | 2 | 0 | ||
M stage | ||||
0 | 214 | 228 | 4.247 | 0.039 |
1 | 15 | 6 | ||
TNM stage | ||||
I | 114 | 142 | 2.598 | 0.009 |
II | 58 | 52 | ||
III | 42 | 34 | ||
IV | 15 | 6 | ||
Anatomic location | ||||
L-Lower | 37 | 37 | 8.344 | 0.138 |
L-Upper | 52 | 57 | ||
R-Lower | 41 | 46 | ||
R-Middle | 14 | 5 | ||
R-Upper | 76 | 86 | ||
Uncertain | 9 | 3 | ||
